Bioethics, Ltd. is a shell company that conducts no active business operations and is seeking business opportunities for acquisition or participation by the Company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company did not generate revenue.

Employees

Sector

Investment Holding Companies

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Delayed OTC Markets 22:57:14 13/11/2025 +03			5-day change	1st Jan Change
0.005100 ^USD	-.--%		-.--%	-

13/08/25	Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/08/25	Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt	CI

Market Cap	18.36K 16.47K 15.23K 13.79K 25.77K 1.75M 26.08K 182K 72.53K 915K 68.9K 67.44K 2.9M	P/E 2023	-2.46x	P/E 2024	-9.7x
Enterprise Value	589K 529K 489K 443K 827K 56.13M 837K 5.85M 2.33M 29.37M 2.21M 2.17M 93.25M	EV / Sales 2023	-	EV / Sales 2024	-
Free-Float	10.98%	Yield 2023 *	-	Yield 2024	-

13/08/25	Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/08/25	Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt	CI
19/11/24	Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
19/08/24	Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
26/06/24	SILQ Technologies Corporation entered into a non-binding letter of intent to acquire Bioethics, Ltd. in a reverse merger transaction.	CI
20/05/24	Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04/24	Bioethics, Ltd. Appoints Doug Morris as A Member of Board of Directors	CI
11/04/24	Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/04/24	Bioethics, Ltd. Auditor Raises 'Going Concern' Doubt	CI
15/11/23	Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
09/08/23	Bioethics, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
20/05/23	Bioethics, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
17/04/23	Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

26/06/24	Bioethics : Proposed Transaction Form 8 K	PU
17/04/23	BIOETHICS LTD Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
21/11/22	BIOETHICS LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
15/08/22	BIOETHICS LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
24/05/22	BIOETHICS LTD Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ

Bioethics, Ltd. Stock

Stocks

BOTH

US09059E2090

Investment Holding Companies

Valuation: Bioethics, Ltd.

Chart: Bioethics, Ltd.

Latest news: Bioethics, Ltd.

Press Releases: Bioethics, Ltd.

Price Extremes

Managers and Directors: Bioethics, Ltd.

Shell Companies

Financials

Company Profile

Manager	Title	Age	Since
Mark Scharmann CEO	Chief Executive Officer	67	24/07/2015
Douglas Morris PRN	Corporate Officer/Principal	70	26/04/2024

Director	Title	Age	Since
Mark Scharmann BRD	Director/Board Member	67	24/07/2015
Elliott N. Taylor BRD	Director/Board Member	67	19/12/2019
Douglas Morris BRD	Director/Board Member	70	26/04/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOETHICS, LTD.	-.--%	-.--%	-99.59%	-97.57%	18.36K
INVESTOR AB	-0.10%	+4.07%	+33.53%	+109.85%	131B
INDUSTRIVÄRDEN AB	+0.29%	+4.06%	+32.11%	+86.04%	22.76B
HAL TRUST	-0.24%	+4.04%	+24.49%	+61.10%	17.13B
MERITZ FINANCIAL GROUP INC.	+6.40%	+0.69%	+17.11%	+164.39%	14.78B
LUNDBERG B	+0.43%	+3.82%	+14.59%	+30.43%	14.57B
INVESTMENT AB LATOUR	+0.23%	+4.14%	-11.43%	+14.21%	13.9B
BAJAJ HOLDINGS & INVESTMENT LIMITED	-2.87%	-7.22%	-20.60%	+50.83%	12.21B
WASHINGTON H. SOUL PATTINSON AND COMPANY LIMITED	+1.18%	-0.89%	+19.44%	+34.48%	12.04B
KINGDOM HOLDING COMPANY	-1.08%	-5.99%	+52.36%	+71.90%	11.91B
Average	+0.51%	+0.36%	+6.20%	+52.57%	25.04B
Weighted average by Cap.	+0.33%	+1.48%	+25.80%	+89.33%

	2023	2024
Net sales	-	-
Net income	-97.15K -87.16K -80.59K -72.98K -136K -9.25M -138K -964K -384K -4.84M -365K -357K -15.37M	-177K -159K -147K -133K -248K -16.85M -251K -1.75M -699K -8.82M -664K -650K -28M
Net Debt	443K 397K 367K 333K 621K 42.15M 629K 4.39M 1.75M 22.06M 1.66M 1.63M 70.03M	571K 512K 474K 429K 801K 54.38M 811K 5.66M 2.26M 28.46M 2.14M 2.1M 90.35M

1 year	0.01	0.01
3 years	0.01	3.6
5 years	0.01	3.6
10 years	0.01	16